Other Income/Expenses (Net)

-$365.00M

Quarterly · Period ending: Jun 30, 2026 · USD

Latest reported-$365.00Mperiod endingJun 30, 2026

AZN Quarterly Other Income/Expenses (Net) (-$1.75B → -$365.00M)

Quarterly Other Income/Expenses (Net)

High-resolution chart · PNG

AZN other income/expenses (net) history

Quarterly · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

AstraZeneca PLC Ordinary Shares Other Income/Expenses (Net) — Quarterly (USD)
Period ending	Other Income/Expenses (Net) (USD)
Jun 30, 2001	21,000,000
Mar 31, 2001	64,789,604
Dec 31, 2000	122,322,483
Sep 30, 2000	9,877,954
Jun 30, 2000	12,059,690
Mar 31, 2000	40,947,183
Dec 31, 1999	-818,648,052
Sep 30, 1999	31,000,000
Jun 30, 1999	36,000,000
Mar 31, 1999	-4,521,500,000
Dec 31, 1998	5,286,652,120
Sep 30, 1998	-2,330,200,000
Jun 30, 1998	344,000,000
Mar 31, 1998	-2,417,500,000
Dec 31, 1997	4,486,390,173
Sep 30, 1997	-2,099,400,000
Jun 30, 1997	-2,284,000,000
Mar 31, 1997	-2,284,000,000
Dec 31, 1996	2,758,757,362
Sep 30, 1996	-2,313,600,000
Jun 30, 1996	-2,278,500,000
Mar 31, 1996	-2,278,500,000
Dec 31, 1995	4,123,708,331
Sep 30, 1995	-1,935,000,000
Jun 30, 1995	19,200,000
Mar 31, 1995	-2,017,100,000
Dec 31, 1994	3,984,522,867
Sep 30, 1994	-1,752,800,000
Jun 30, 1994	-1,836,800,000
Mar 31, 1994	-1,836,800,000
Dec 31, 1993	4,014,829,536
Sep 30, 1993	-1,537,000,000
Jun 30, 1993	-1,748,500,000
Mar 31, 1993	-1,748,500,000